mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.068 |
0.04 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.04 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.04 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.04 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.068 |
0.04 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.04 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.04 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.093 |
0.04 |
mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.04 |